Lipodystrophy in HIV infected patients on long term Antiretroviral therapy in western Kenya
dc.contributor.author | Diero, L. O. | |
dc.contributor.author | Fife, K. H. | |
dc.contributor.author | Kaloustian, K. W. | |
dc.contributor.author | Sidle, J. | |
dc.contributor.author | Dube, M. P. | |
dc.contributor.author | Fife, R. S. | |
dc.contributor.author | Mureithi, J. | |
dc.contributor.author | Mwangi, A. | |
dc.contributor.other | Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya) | en |
dc.date.accessioned | 2007-10-25T15:32:43Z | |
dc.date.available | 2007-10-25T15:32:43Z | |
dc.date.issued | 2007 | |
dc.description.abstract | Changes in fat distribution has been observed in patients on highly active antiretroviral therapy. The frequently reported drugs that cause fat redistribution are stavudine and protease inhibitors. Stavudine also causes a high incidence of metabolic complications and peripheral neuropathy. | en |
dc.identifier.uri | https://hdl.handle.net/1805/1158 | |
dc.language.iso | en | en |
dc.publisher | Association of Kenya Physicians | en |
dc.subject | Lipodystrophy | en |
dc.subject | HIV | en |
dc.subject | Antiretroviral therapy | en |
dc.subject | Kenya | en |
dc.subject | Africa | en |
dc.subject.lcsh | Kenya | |
dc.subject.mesh | HIV-Associated Lipodystrophy Syndrome | |
dc.subject.mesh | Antiretroviral Therapy, Highly Active | |
dc.subject.mesh | HIV | |
dc.title | Lipodystrophy in HIV infected patients on long term Antiretroviral therapy in western Kenya | en |
dc.type | Presentation | en |